Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEOGENOMICS INC | Pres & Chief Operating Officer | Common Stock | 90.8K | $1.39M | $15.36 | Apr 1, 2025 | Direct |
NEOGENOMICS INC | Pres & Chief Operating Officer | Stock Option (Right to Buy) | 94.5K | $1.32M | $43.95 | Apr 1, 2025 | Direct |
NEOGENOMICS INC | Pres & Chief Operating Officer | Restricted Stock Unit | 52.7K | $809K | $15.36 | Apr 1, 2025 | Direct |
NEOGENOMICS INC | Pres & Chief Operating Officer | Restricted Stock Unit | 19.2K | $286K | $14.86 | May 11, 2024 | Direct |
NEOGENOMICS INC | Pres & Chief Operating Officer | Performance Stock Unit | 17.9K | $275K | $15.36 | Apr 1, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NEO | NEOGENOMICS INC | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | Pres & Chief Operating Officer |
NEO | NEOGENOMICS INC | Feb 21, 2025 | 5 | $0 | 4 | Feb 25, 2025 | Chief Commerical Officer |
NEO | NEOGENOMICS INC | Jan 14, 2025 | 1 | $0 | 4 | Jan 16, 2025 | Chief Commerical Officer |
NEO | NEOGENOMICS INC | Dec 1, 2024 | 1 | $0 | 4 | Dec 3, 2024 | Chief Commerical Officer |
NEO | NEOGENOMICS INC | May 11, 2024 | 4 | -$34.8K | 4 | May 14, 2024 | Chief Commerical Officer |
NEO | NEOGENOMICS INC | May 2, 2024 | 3 | $0 | 4 | May 3, 2024 | Chief Commerical Officer |
NEO | NEOGENOMICS INC | Feb 23, 2024 | 3 | $0 | 4 | Feb 27, 2024 | President, Clinical Services |
NEO | NEOGENOMICS INC | Dec 1, 2023 | 1 | $0 | 4 | Dec 5, 2023 | President, Clinical Services |
NEO | NEOGENOMICS INC | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | President, Clinical Services |
NEO | NEOGENOMICS INC | Dec 1, 2022 | 2 | $0 | 4 | Dec 5, 2022 | President, Clinical Services |
NEO | NEOGENOMICS INC | Nov 21, 2022 | 0 | $0 | 3 | Dec 1, 2022 | President, Clinical Services |